Log in

NYSE:SNN - Smith & Nephew Stock Price, Forecast & News

-1.22 (-2.57 %)
(As of 02/28/2020 01:54 AM ET)
Today's Range
Now: $46.32
50-Day Range
MA: $48.88
52-Week Range
Now: $46.32
Volume900,500 shs
Average Volume555,277 shs
Market Capitalization$20.26 billion
P/E Ratio22.93
Dividend Yield1.18%
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies



Sales & Book Value

Annual Sales$5.14 billion
Cash Flow$2.49 per share
Book Value$11.76 per share



Market Cap$20.26 billion
Next Earnings DateN/A

Receive SNN News and Ratings via Email

Sign-up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter.

Smith & Nephew (NYSE:SNN) Frequently Asked Questions

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew declared a semi-annual dividend on Monday, February 24th. Investors of record on Friday, April 3rd will be paid a dividend of $0.462 per share on Wednesday, May 6th. This represents a yield of 1.4%. The ex-dividend date is Thursday, April 2nd. View Smith & Nephew's Dividend History.

How were Smith & Nephew's earnings last quarter?

Smith & Nephew plc (NYSE:SNN) announced its quarterly earnings data on Monday, November, 17th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.39 by $0.59. View Smith & Nephew's Earnings History.

What guidance has Smith & Nephew issued on next quarter's earnings?

Smith & Nephew updated its FY 2020 IntraDay earnings guidance on Thursday, February, 20th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $5.344-5.395 billion.

What price target have analysts set for SNN?

5 equities research analysts have issued 1 year target prices for Smith & Nephew's stock. Their forecasts range from $6.00 to $52.00. On average, they expect Smith & Nephew's share price to reach $29.00 in the next year. This suggests that the stock has a possible downside of 37.4%. View Analyst Price Targets for Smith & Nephew.

What is the consensus analysts' recommendation for Smith & Nephew?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Smith & Nephew.

Has Smith & Nephew been receiving favorable news coverage?

Media headlines about SNN stock have been trending very negative this week, InfoTrie reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Smith & Nephew earned a news sentiment score of -3.2 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. View News Stories for Smith & Nephew.

Are investors shorting Smith & Nephew?

Smith & Nephew saw a decrease in short interest in the month of January. As of January 31st, there was short interest totalling 1,750,000 shares, a decrease of 7.9% from the January 15th total of 1,900,000 shares. Based on an average trading volume of 592,200 shares, the days-to-cover ratio is presently 3.0 days. Approximately 0.4% of the company's shares are short sold. View Smith & Nephew's Current Options Chain.

Who are some of Smith & Nephew's key competitors?

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), Gilead Sciences (GILD), AbbVie (ABBV), RPM International (RPM), Alibaba Group (BABA), Pfizer (PFE), Alexion Pharmaceuticals (ALXN), Vertex Pharmaceuticals (VRTX), Bristol-Myers Squibb (BMY) and CVS Health (CVS).

Who are Smith & Nephew's key executives?

Smith & Nephew's management team includes the folowing people:
  • Mr. Namal Nawana, CEO & Exec. Director (Age 48)
  • Mr. Graham Timothy Baker, CFO & Exec. Director (Age 51)
  • Mr. Mark Gladwell, Pres of Global Operations (Age 44)
  • Ms. Catheryn O'Rourke, Chief Legal & Compliance Officer (Age 46)
  • Mr. Joe Metzger, Sr. VP of Marketing Services & Communications

Who are Smith & Nephew's major shareholders?

Smith & Nephew's stock is owned by a number of of retail and institutional investors. Top institutional investors include WCM Investment Management LLC (0.96%), Nuance Investments LLC (0.76%), Cambiar Investors LLC (0.73%), FMR LLC (0.26%), Bank of America Corp DE (0.26%) and Envestnet Asset Management Inc. (0.15%).

Which major investors are selling Smith & Nephew stock?

SNN stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Cambiar Investors LLC, State Street Corp, Connor Clark & Lunn Investment Management Ltd., New York State Common Retirement Fund, Jane Street Group LLC, Barclays PLC and Goldman Sachs Group Inc..

Which major investors are buying Smith & Nephew stock?

SNN stock was acquired by a variety of institutional investors in the last quarter, including Nuance Investments LLC, WCM Investment Management LLC, Envestnet Asset Management Inc., Natixis Advisors L.P., Citigroup Inc., Raymond James & Associates, M&T Bank Corp and Stifel Financial Corp.

How do I buy shares of Smith & Nephew?

Shares of SNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Smith & Nephew's stock price today?

One share of SNN stock can currently be purchased for approximately $46.32.

How big of a company is Smith & Nephew?

Smith & Nephew has a market capitalization of $20.26 billion and generates $5.14 billion in revenue each year. The medical equipment provider earns $600 million in net income (profit) each year or $2.02 on an earnings per share basis. Smith & Nephew employs 16,377 workers across the globe.View Additional Information About Smith & Nephew.

What is Smith & Nephew's official website?

The official website for Smith & Nephew is http://www.smith-nephew.com/.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is 15 ADAM STREET, LONDON X0, WC2N 6LA. The medical equipment provider can be reached via phone at 44-20-7401-7646 or via email at [email protected]

MarketBeat Community Rating for Smith & Nephew (NYSE SNN)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  375 (Vote Outperform)
Underperform Votes:  635 (Vote Underperform)
Total Votes:  1,010
MarketBeat's community ratings are surveys of what our community members think about Smith & Nephew and other stocks. Vote "Outperform" if you believe SNN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Featured Article: What is a Swap?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel